| Name | Title | Contact Details |
|---|
At PopHealthCare, we believe healthcare should be personal. For us, that means bringing care to those who need it most, where they will be able to achieve their health goals best–at home or wherever they reside. Using in-home assessments and cutting-edge analytics, we identify high-risk patients and partner with health plans to keep them out of the hospital with our care team of compassionate, smart, deeply committed healthcare providers available 24/7. This commitment and integrity expands to all areas of our business. With over 22 clients in 17 states, PopHealthCare offers a fully integrated approach to care delivery, risk adjustment and quality enhancements, serving the highest risk populations with unwavering dedication. Our risk adjustment solutions include not only risk adjustment, but also chart retrievals and analytics and reporting, to help you effectively manage your risk adjustment program. Our goal is to facilitate risk score accuracy and help clients plan for the future with more precision, leveraging our unique combination of technology, in-depth industry expertise, and concierge-level service. Emcara Health, PopHealthCare`s value-based national medical group that does house calls for vulnerable populations, delivers personalized, attentive care either as the Primary Care Provider (PCP) or in collaboration with a patient`s community-based PCP. PopHealthcare`s success in spearheading the transformation of in-home care enables Emcara Health to deliver industry-leading outcomes in patient experience, care quality, cost of care, health equity, and employee satisfaction. As part of the GuideWell family of companies, we are working hard every day to improve the delivery of care through new innovative models that provide superior health outcomes for patients and our partners.
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Ascension is a faith-based healthcare organization dedicated to transformation through innovation across the continuum of care. As the largest non-profit health system in the U.S. and the world`s largest Catholic health system, Ascension is committed to delivering compassionate, personalized care to all, with special attention to persons living in poverty and those most vulnerable. In FY2016, Ascension provided more than $1.8 billion in care of persons living in poverty and other community benefit programs. Ascension includes approximately 160,000 associates and 36,000 aligned providers. Ascension`s Healthcare Division operates 2,500 sites of care – including 141 hospitals and more than 30 senior living facilities – in 24 states and the District of Columbia, while its Solutions Division provides a variety of services and solutions including physician practice management, venture capital investing, investment management, biomedical engineering, facilities management, clinical care management, information services, risk management, and contracting through Ascension`s own group purchasing organization.
Suncoast Communities Blood Bank is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We build applications that use speech and fine motor to detect subtle changes in brain health. We are rooted in neuroscience with an award winning, first to market technology platform that turns the devices we use every day into objective brain health monitors.